Treatment for Hunter syndrome approved.
D017277:Drug Approval; D006801:Humans; D007066:Iduronate Sulfatase / Q000627:therapeutic use*; D016532:Mucopolysaccharidosis II / Q000188:drug therapy*; D009965:Orphan Drug Production; D014481:United States; D014486:United States Food and Drug Administration
D007066:Iduronate Sulfatase; C517982:idursulfase